GLP-1 receptor agonists linked to lower medication use and reduced headaches, visual disturbances or blindness, and papilledema.

For older adults with diabetes, there is no evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.

We've got fresh evidence for how weight can quickly be regained after weight-loss programs stop – but rather than looking at ...

As life-extending technologies and aging interventions proliferate, questions surround who will be granted access to a longer ...